Search

Search Results
Results 1431 - 1439 of 1439 for chronic pain syndrome
  • Lenest 30 ED
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Lenest 30 ED intended for persons living in Australia.
  • Norimin
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Norimin intended for persons living in Australia.
  • Norimin-1
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Norimin-1 intended for persons living in Australia.
  • Tenofovir Disoproxil Viatris
    Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Tenofovir Disoproxil Viatris (tenofovir disoproxil maleate 300 mg) intended for persons living in Australia.
  • Bisolvon Chesty Forte Tablets
    Drug - 6 May 2022
    Consumer Medicine Information (CMI) about Bisolvon Chesty Forte Tablets intended for persons living in Australia.
  • Bisolvon Chesty Kids Strawberry Oral Liquid
    Drug - 1 Jul 2021
    Consumer Medicine Information (CMI) about Bisolvon Chesty Kids Strawberry Oral Liquid intended for persons living in Australia.
  • Bisolvon Chesty Forte Oral Liquid
    Drug - 1 Jul 2021
    Consumer Medicine Information (CMI) about Bisolvon Chesty Forte Oral Liquid intended for persons living in Australia.
  • Meden-Inmed Sp. z o.o.
    Supplier - 29 Jun 2013
    Meden-Inmed was founded in 1989 as a company employing two people. Since then, it has gained a strong market position through the hard work and reliability.
  • Genova Diagnostics
    Supplier - 26 Dec 2016
    Headquartered in Asheville, N.C., Genova Diagnostics is a global clinical laboratory, pioneering a systems approach that supports healthcare providers in the personalized treatment and prevention of...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback